Dhampur Bio Organics Slips into Red Despite Revenue Uptick in Q1 FY26

Unknown Apr 02, 2026 900 Views

Mixed Start to the Fiscal Year Amid Margin Compression Dhampur Bio Organics Ltd reported its consolidated financial results for the quarter ended June 2025, revealing a challenging start to FY26. While revenue from operations rose to Rs 784 crore, the company posted a net loss of Rs 22 crore,...

Mixed Start to the Fiscal Year Amid Margin Compression

Dhampur Bio Organics Ltd reported its consolidated financial results for the quarter ended June 2025, revealing a challenging start to FY26. While revenue from operations rose to Rs 784 crore, the company posted a net loss of Rs 22 crore, reversing its profit trajectory from the same period last year. The results reflect operational headwinds, margin pressures, and sectoral volatility in the sugar and ethanol segments.

Key Highlights from Q1 FY26

Consolidated revenue from operations stood at Rs 784 crore, up 67.5% year-on-year from Rs 468 crore in Q1 FY25
Net loss widened to Rs 22 crore, compared to a net profit of Rs 39 crore in the year-ago quarter
EBITDA declined sharply to Rs 27 crore, down 66% from Rs 81 crore in Q1 FY25
Operating margin contracted to 3.43%, a steep drop from 17.53% in the previous quarter

Segment Performance and Operational Trends

Sugar Division

Sugar recovery rates declined due to pest-related crop damage and erratic weather
SAP (State Advised Price) uncertainty in Uttar Pradesh impacted cost planning and procurement
Inventory buildup and lower realizations weighed on profitability

Biofuels and Spirits

Ethanol volumes remained stable, but margins were compressed due to higher molasses costs
ENA (Extra Neutral Alcohol) production saw moderate growth, with new contracts from institutional buyers
Country liquor segment continued its upward trajectory, contributing Rs 265 crore in revenue

Power Co-generation

Lower bagasse availability and grid constraints led to a 12% drop in power exports
The segment’s contribution to topline remained marginal

Quarter-on-Quarter Comparison

Revenue rose 67.5% QoQ from Rs 468 crore in Q4 FY25 to Rs 784 crore in Q1 FY26
Net profit turned negative, falling from Rs 39 crore in Q4 to a loss of Rs 22 crore
EBITDA margin dropped from 17.53% to 3.43%, reflecting cost inflation and operational inefficiencies

Management Commentary and Strategic Focus

Chairman Vijay Kumar Goel acknowledged the challenges, stating that the company is prioritizing cost control, crop yield enhancement, and ethanol capacity expansion. The management remains committed to its long-term strategy of diversifying revenue streams and improving operational resilience.

Key initiatives underway:

Expansion of ENA capacity at the Asmoli plant by 20 KLPD
Strategic tie-ups with state-run liquor boards for bulk supply contracts
Digitization of procurement and logistics to reduce turnaround time and improve traceability

Financial Health and Market Sentiment

ROE declined to 3.67%, while interest coverage ratio remained below 1.5x
Promoter holding remained stable at 50.79%, with minimal pledging
FII holding dropped to 0.66%, indicating cautious institutional sentiment
DBOL shares closed at Rs 88.41 on July 25, 2025, down 2.84% for the day

Outlook and Investment Considerations

Dhampur Bio Organics faces a tough short-term outlook due to margin compression and sectoral headwinds. However, its long-term prospects hinge on ethanol expansion, country liquor growth, and operational efficiency. Investors may adopt a wait-and-watch approach until margin stability and earnings visibility improve.

Source: Tickertape ,Screener , Moneycontrol , Dhampur Bio Organics Ltd ,5 BSE Corporate Filings

Stay Ahead – Explore Now! Styrenix Performance Materials Tax Demand of 43.8 Million Rupees Deleted